Interview with Andreas Windischbauer, CEO, Herba Chemosan
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Address: Haidestraße 4, 1110 Vienna,Austria
Tel: +43 1 401 04-0
Web: http://www.herba-chemosan.at/de/home/index.jsp
The Herba Apotheker-AG, with a market share of 43% not only the leading pharmaceutical wholesaler and service provider in Austria, but also has the highest level of dynamics. Seven companies form over Austria’s densest logistics network for the provision of drugs and health products. They guarantee fast operations and simplified work processes and thus for better quality control and higher deliverability. But the stock range comprises more than 42,000 articles. Several times a day we serve over 1,000 pharmacies, doctors and hospitals. In addition, the Herba Group offers its customers to support a comprehensive portfolio of services in the areas of marketing and organization. Nearly 1,000 employees contribute to the success of the company. Since 2000, the Herba Apotheker-AG is part of the German Celesio AG based in Stuttgart, whose majority shareholder is the Franz HANIEL jr. GmbH , headquartered in Duisburg.
Herba is the industry leader in pharmaceutical distribution. Almost every second drug that is delivered in an Austrian chemist on Tara, comes from one of our seven distribution centers. In addition to the largest assortment of drugs and health products, we offer our customers special ranges and other services in the areas of raw materials, kits, pharmacy IT and through our subsidiary Sanova on its own assortment line.
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
2012 represents the 123rd anniversary of Schülke&Mayr. There have been many changes over the years, but do you think the ideals and values of today reflect the original vision set…
What are the historical and strategic factors which position Austria as one of the best healthcare systems in the world today? The main principles of the Austrian health care system…
You have been with Bayer for almost 15 years. What would you say defines your loyalty to the company, and has the time so far met your original expectations? Bayer…
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
What initially attracted you to Biotest back in 2001 and what do you think attracts industry professionals to Biotest today? I started my pharmaceutical career at Behring in Austria, doing…
You previously worked as CSO for onepharm; what was the motivation for creating Savira? OS: When I was working at onepharm, the organization was focused on anti-influenza and anti-inflammatory drug…
You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the…
You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering…
What have been the focus areas for the association in improving the wellbeing of the life science biotech industry and what have been the key milestones/achievements since 2008 in providing…
Dr. Rumler, what is your assessment of the subsidiary’s current strengths and weaknesses, after three and half years of tenure? Pfizer currently ranks second in the overall pharmaceutical market in…
Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first…
Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed…
See our Cookie Privacy Policy Here
